This comment proposes a totality-of-the-circumstances approach to analyzing biological molecules under § 101 such that both the structure and its information is examined. Part II of this note reviews relevant precedent in patent law. Part III analyzes the Federal Circuit\u27s Myriad decision, and Part IV explains the potential effects of the recent Supreme Court decision Mayo Collaborative Services v. Prometheus Laboratories. Finally, in Part V, the patent eligibility of human genes is examined. Analyzing this issue under the proposed totality-of-the-circumstances approach, this article concludes that isolated human genes are not patentable
There is significant domestic and international opposition to gene patents based on the fact that ge...
In a recent decision (AMP v. USPTO) from the US District Court, patent claims directed at DNA sequen...
The United States District Court for the Southern District of New York recently held in Association ...
Genes are the fundamental building blocks of all living things. They dictate hair color, eye color, ...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
By the summer of 2013, the United States Supreme Court should issue an opinion in Myriad v. AMP, a c...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
The controversy over human gene patents was reignited in March 2010 when a US Federal District Court...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
In the pending case Myriad Genetics v. Association for Molecular Pathology, the United States Suprem...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
Gene patents have proven to be enormously controversial, evoking a strong response from many categor...
There is significant domestic and international opposition to gene patents based on the fact that ge...
In a recent decision (AMP v. USPTO) from the US District Court, patent claims directed at DNA sequen...
The United States District Court for the Southern District of New York recently held in Association ...
Genes are the fundamental building blocks of all living things. They dictate hair color, eye color, ...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
By the summer of 2013, the United States Supreme Court should issue an opinion in Myriad v. AMP, a c...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
The controversy over human gene patents was reignited in March 2010 when a US Federal District Court...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
In the pending case Myriad Genetics v. Association for Molecular Pathology, the United States Suprem...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
Gene patents have proven to be enormously controversial, evoking a strong response from many categor...
There is significant domestic and international opposition to gene patents based on the fact that ge...
In a recent decision (AMP v. USPTO) from the US District Court, patent claims directed at DNA sequen...
The United States District Court for the Southern District of New York recently held in Association ...